Showing results (161-170 of 304) with videos related to
Sort By:
Pageof 31
Critical Reviews in Oncology/Hematology|November 29, 2024
Warming-up the immune cell engagers (ICEs) era in breast cancer: state of the art and future directionsAldo Caltavituro, Roberto Buonaiuto, Fabio Salomone, et al.Critical Reviews in Oncology/Hematology|December 8, 2015
Current challenges in HER2-positive breast cancerFabio Puglisi, Caterina Fontanella, Vito Amoroso, et al.International Journal of Molecular Sciences|November 11, 2022
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic TestsMariarosaria Saponaro, Luigi Annunziata, Antonella Turla, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancerElena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.Journal of Experimental & Clinical Cancer Research : CR|May 17, 2011
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trialsFederica Cuppone, Emilio Bria, Vanja Vaccaro, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 5, 2022
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity riskElena De Mattia, Marco Silvestri, Jerry Polesel, et al.Future Oncology (London, England)|March 13, 2018
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapyElena Ongaro, Lorenzo Gerratana, Marika Cinausero, et al.Frontiers in Oncology|October 18, 2024
Real world clinical outcomes from targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer: data from a large cohort at a national cancer instituteLorenzo Vinante, Jayant Sharad Vaidya, Angela Caroli, et al.Cancers|March 10, 2022
HER2-CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients' Survival in HER2-Positive Metastatic Gastric AdenocarcinomaValli De Re, Lara Alessandrini, Giulia Brisotto, et al.Pageof 31